Aline Noizet

Digital

Aline Noizet, founder of Digital Health Connector, talks with Deep Dive editor Eloise McLennan about the relationships that make innovation possible.

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.